| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |